Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.70 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.70 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.70 |
| ▸ | CHAT | P28329 | 2/20 | 0.45 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.45 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | QDPR | P09417 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16433677 | 0.88 | SLC6A4 (0.56) | SLC22A2SLC22A1SLC22A3SLC6A4PABPC1 | |
| SCHEMBL1108049 | 0.88 | SLC22A2 (0.48) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| SCHEMBL25583351 | 0.85 | SLC22A2 (0.52) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL598047 | 0.85 | SLC22A2 (0.46) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| SCHEMBL14596523 | 0.85 | SLC22A2 (0.46) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| Iodide SCHEMBL5145509 | 0.85 | SLC22A2 (0.46) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| Bromide SCHEMBL4084634 | 0.85 | SLC22A2 (0.46) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| SCHEMBL12240437 | 0.83 | SLC22A2 (0.44) | SLC22A2SLC22A1SLC22A3SLC6A4 | |
| SCHEMBL37321 | 0.83 | SLC22A2 (1.00) | SLC22A2SLC22A1SLC22A3SLC6A4CHAT | |
| SCHEMBL8827505 | 0.83 | SLC22A2 (1.00) | SLC22A2SLC22A1SLC22A3SLC6A4CHAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1457813-B1 | An improved electrochromic medium capable of producing a pre-selected color | GENTEX CORP (US) | 2007-01-24 | — | — | EP | claimed |
| EP-1457813-A2 | An improved electrochromic medium capable of producing a pre-selected color | Gentex Corporation (US) | 2004-09-15 | — | — | EP | claimed |
| EP-0972227-B1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORP (US) | 2004-07-14 | — | — | EP | claimed |
| US-6020987-A | Electrochromic medium capable of producing a pre-selected color | GENTEX CORPORATION (US) | 2000-02-01 | — | — | US | claimed |
| EP-0972227-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 2000-01-19 | — | — | EP | claimed |
| WO-1998044384-A1 | AN IMPROVED ELECTROCHROMIC MEDIUM CAPABLE OF PRODUCING A PRE-SELECTED COLOR | GENTEX CORPORATION (US) | 1998-10-08 | — | — | WO | claimed |
| CN-118707779-A | Electrochromic device, method of making and operating the same | 维特罗平板玻璃有限责任公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114902128-B | Electrochromic device, method of making and operating the same | 维特罗平板玻璃有限责任公司 | 2024-07-26 | — | — | CN | disclosed |
| US-20230340319-A1 | Electrochromic Devices and Compositions Including Cathodic Zwitterions | VITRO FLAT GLASS LLC | 2023-10-26 | — | — | US | disclosed |
| WO-2023205269-A1 | ELECTROCHROMIC DEVICES AND COMPOSITIONS INCLUDING CATHODIC ZWITTERIONS | VITRO FLAT GLASS LLC (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20230178784-A1 | REDOX RELAY FLOW BATTERIES AND METHODS OF MAKING THE SAME | OHIO STATE INNOVATION FOUNDATION | 2023-06-08 | — | — | US | disclosed |
| CN-114902128-A | Electrochromic device, method of manufacturing and operating the same | 维特罗平板玻璃有限责任公司 | 2022-08-12 | — | — | CN | disclosed |
| US-11215935-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2022-01-04 | — | — | US | disclosed |
| EP-3221420-B1 | PHOTOCHROMIC-ELECTROCHROMIC COMPOSITIONS | SWITCH MAT INC (CA) | 2021-02-17 | — | — | EP | disclosed |
| US-20200341392-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20200341393-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-10647913-B2 | Photochromic-electrochromic compositions | SWITCH MATERIALS INC. (CA) | 2020-05-12 | — | — | US | disclosed |
| US-20190002758-A1 | ORGANIC COMPOUND, ELECTROCHROMIC DEVICE, ELECTROCHROMIC APPARATUS, OPTICAL FILTER, IMAGE PICKUP APPARATUS, LENS UNIT, AND WINDOW MEMBER | CANON KABUSHIKI KAISHA (JP) | 2019-01-03 | — | — | US | disclosed |
| US-20170355901-A1 | PHOTOCHROMIC-ELECTROCHROMIC COMPOSITIONS | SOLUTIA CANADA INC. (CA) | 2017-12-14 | — | — | US | disclosed |
| US-20070020479-A1 | Luminescent-polymer composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002758-A1 | ORGANIC COMPOUND, ELECTROCHROMIC DEVICE, ELECTROCHROMIC APPARATUS, OPTICAL FILTER, IMAGE PICKUP APPARATUS, LENS UNIT, AND WINDOW MEMBER | HCN2, EML4, KCNJ6 | SLC22A2 1234/4885SLC22A1 1385/4885SLC22A3 1595/4885 |
| US-20230340319-A1 | Electrochromic Devices and Compositions Including Cathodic Zwitterions | KCNH3, AFF4, CHRM2 | SLC22A2 1142/4885SLC22A1 1419/4885SLC22A3 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.